BDP/formoterol NEXT DPI

DRUG2 trials

Sponsors

Chiesi Farmaceutici S.p.A.

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 1

Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients

CompletedNCT01176747

Chiesi Farmaceutici S.p.A.Asthma, Pulmonary Disease, Chronic Obstructive

Start: 2010-08-31End: 2010-10-31Updated: 2021-10-29

Phase 3

A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma

CompletedNCT00862394

Chiesi Farmaceutici S.p.A.Asthma

Start: 2009-02-28End: 2010-01-31Updated: 2018-04-13